Cargando…

Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease

Patients with chronic liver disease (CLD) often develops glucose intolerance. We explored the prevalence of diabetes mellitus in viral CLD, and analyzed factors profoundly affecting the diabetic angiopathies. 229 CLD patients (124 chronic hepatitis and 105 liver cirrhosis) entered the study. The dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuriyama, Shoko, Miwa, Yoshiyuki, Fukushima, Hideki, Nakamura, Hironori, Toda, Katsuhisa, Shiraki, Makoto, Nagaki, Masahito, Yamamoto, Mayumi, Tomita, Eiichi, Moriwaki, Hisataka
Formato: Texto
Lenguaje:English
Publicado: the Society for Free Radical Research Japan 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127229/
https://www.ncbi.nlm.nih.gov/pubmed/18188413
http://dx.doi.org/10.3164/jcbn.40.116
_version_ 1782141984871284736
author Kuriyama, Shoko
Miwa, Yoshiyuki
Fukushima, Hideki
Nakamura, Hironori
Toda, Katsuhisa
Shiraki, Makoto
Nagaki, Masahito
Yamamoto, Mayumi
Tomita, Eiichi
Moriwaki, Hisataka
author_facet Kuriyama, Shoko
Miwa, Yoshiyuki
Fukushima, Hideki
Nakamura, Hironori
Toda, Katsuhisa
Shiraki, Makoto
Nagaki, Masahito
Yamamoto, Mayumi
Tomita, Eiichi
Moriwaki, Hisataka
author_sort Kuriyama, Shoko
collection PubMed
description Patients with chronic liver disease (CLD) often develops glucose intolerance. We explored the prevalence of diabetes mellitus in viral CLD, and analyzed factors profoundly affecting the diabetic angiopathies. 229 CLD patients (124 chronic hepatitis and 105 liver cirrhosis) entered the study. The diagnosis of diabetes was made with the criteria by World Health Organization. Laboratory investigation included serum asparate aminotransferase, alanine aminotransferase, albumin, fasting blood sugar, hemoglobin A1c (HbA1c), fasting immunoreactive insulin, and HOMA-R (FBS*IRI/405). The incidence of macro- and microangiopathy were also examined. Forty (17.5%) CLD patients were diagnosed diabetes, giving a significantly higher incidence than that of general cohort (5.3%) (p<0.001). Among them, 12 (30%) had the triopathy, significantly lower than that in a matched group of diabetic patients without CLD (65%) (p<0.001). Significantly increased levels of HbA1c and HOMA-R were observed in diabetic CLD with angiopathy compared with diabetic CLD without. Incidence of diabetes was increased in viral CLD patients. The rate of diabetic angiopathies in CLD, however, was relatively low, this could be explained by low coagulability in these patients. Poor control of hyperglycemia, partly due to insulin resistance, might explain the onset of angiopathy in diabetic CLD.
format Text
id pubmed-2127229
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher the Society for Free Radical Research Japan
record_format MEDLINE/PubMed
spelling pubmed-21272292008-01-09 Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease Kuriyama, Shoko Miwa, Yoshiyuki Fukushima, Hideki Nakamura, Hironori Toda, Katsuhisa Shiraki, Makoto Nagaki, Masahito Yamamoto, Mayumi Tomita, Eiichi Moriwaki, Hisataka J Clin Biochem Nutr Original Article Patients with chronic liver disease (CLD) often develops glucose intolerance. We explored the prevalence of diabetes mellitus in viral CLD, and analyzed factors profoundly affecting the diabetic angiopathies. 229 CLD patients (124 chronic hepatitis and 105 liver cirrhosis) entered the study. The diagnosis of diabetes was made with the criteria by World Health Organization. Laboratory investigation included serum asparate aminotransferase, alanine aminotransferase, albumin, fasting blood sugar, hemoglobin A1c (HbA1c), fasting immunoreactive insulin, and HOMA-R (FBS*IRI/405). The incidence of macro- and microangiopathy were also examined. Forty (17.5%) CLD patients were diagnosed diabetes, giving a significantly higher incidence than that of general cohort (5.3%) (p<0.001). Among them, 12 (30%) had the triopathy, significantly lower than that in a matched group of diabetic patients without CLD (65%) (p<0.001). Significantly increased levels of HbA1c and HOMA-R were observed in diabetic CLD with angiopathy compared with diabetic CLD without. Incidence of diabetes was increased in viral CLD patients. The rate of diabetic angiopathies in CLD, however, was relatively low, this could be explained by low coagulability in these patients. Poor control of hyperglycemia, partly due to insulin resistance, might explain the onset of angiopathy in diabetic CLD. the Society for Free Radical Research Japan 2007-03 2007-03-14 /pmc/articles/PMC2127229/ /pubmed/18188413 http://dx.doi.org/10.3164/jcbn.40.116 Text en Copyright © 2007 JCBN This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kuriyama, Shoko
Miwa, Yoshiyuki
Fukushima, Hideki
Nakamura, Hironori
Toda, Katsuhisa
Shiraki, Makoto
Nagaki, Masahito
Yamamoto, Mayumi
Tomita, Eiichi
Moriwaki, Hisataka
Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
title Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
title_full Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
title_fullStr Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
title_full_unstemmed Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
title_short Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
title_sort prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127229/
https://www.ncbi.nlm.nih.gov/pubmed/18188413
http://dx.doi.org/10.3164/jcbn.40.116
work_keys_str_mv AT kuriyamashoko prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT miwayoshiyuki prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT fukushimahideki prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT nakamurahironori prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT todakatsuhisa prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT shirakimakoto prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT nagakimasahito prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT yamamotomayumi prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT tomitaeiichi prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease
AT moriwakihisataka prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease